Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Not applicable Country / region: United States Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20016
20025
20039
20047
20056
20065
20078
20088
20097
20107
20113
20122
20132
20143
20155
20164
20174
20183
20198
20205
20216
202213
20238
20249
20257
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108
Terminated27
Recruiting24
Active, not recruiting7
Not yet recruiting6
Enrolling by invitation3
Unknown status3
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Jude Children's Research Hospital12
Fred Hutchinson Cancer Center9
Masonic Cancer Center, University of Minnesota7
Children's Oncology Group6
City of Hope Medical Center6
National Cancer Institute (NCI)6
Roswell Park Cancer Institute6
M.D. Anderson Cancer Center5
Wake Forest University Health Sciences5
University of California, San Francisco4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma182
Leukemia, Myeloid, Acute71
Lymphoma, Non-Hodgkin59
Leukemia, Lymphocytic, Chronic, B-Cell54
Multiple Myeloma51
Hodgkin Disease49
Leukemia49
Burkitt Lymphoma47
Lymphoma, Mantle-Cell47
Myelodysplastic Syndromes44

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.